Business ❯ Finance ❯ Regulations

Securities Regulations

EU Regulations SEBI Regulations Sebi Amendments Securities and Exchange Board of India Investment Advisers IPO Process Exemptions SEC Rules ICDR Regulations Investment Company Act

Liminatus Pharma Faces Nasdaq Delisting After Missing Market-Value Thresholds

A timely appeal by May 27 would pause suspension so the company can seek a Nasdaq Hearings Panel review of its plan to regain compliance.

S&P Weighs Faster S&P 500 Entry for Mega IPOs as Nasdaq’s 15‑Day Rule Starts

NSE Starts IPO Process With Offer for Sale to Long‑Time Shareholders

Reliance Kicks Off Jio Platforms IPO Prep, Targets DRHP Filing Within Weeks

NSE Picks Rothschild as Independent Advisor to Steer IPO Process

Zerodha Reveals 40% Revenue Slide, Weighs Charging for Equity Delivery as Derivatives Rules Squeeze Trading

Westhaven Gold Secures C$1.5 Million Investment from Rob McEwen